REG - FTSE Russell Redx Pharma plc - Redx Pharma
RNS Number : 4476JFTSE Russell09 April 2020
Redx Pharma (UK): Constituent Deletion
Changes in FTSE UK Index Series09 April 2020
Following the cash offer for Redx Pharma (UK, constituent) by RM Special Holdings LLC (non constituent) being declared unconditional in all respects, please see details of affected indexes and effective dates below:
Index
Effective From
Start of TradingFTSE AIM All-Share Index
16 April 2020
For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:
Australia
+1800 653 680
Hong Kong
+852 2164 3333
Japan
+81 3 4563 6346
London
+44 (0) 20 7866 1810
New York
+1866 551 0617
Alternatively please visit our website at www.ftserussell.com
Terms of Use | Copyright © 2020 FTSE Russell
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDFTSSSSFWUESSESL
Recent news on Redx Pharma
See all newsRCS - Redx Pharma plc - Redx Reports Encouraging Zamaporvint Phase 2 Data
AnnouncementREG - AIM Redx Pharma plc - Cancellation - Redx Pharma Plc
AnnouncementREG - Redx Pharma plc - Share Purchases by a PDMR
AnnouncementREG - Redx Pharma plc - Share Purchases by PDMR’s
AnnouncementREG - Redx Pharma plc - Update on AIM Delisting
Announcement